468 related articles for article (PubMed ID: 1406859)
1. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
[TBL] [Abstract][Full Text] [Related]
2. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
Hylek EM; Skates SJ; Sheehan MA; Singer DE
N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
6. Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.
Laupacis A; Sullivan K
CMAJ; 1996 Jun; 154(11):1669-74. PubMed ID: 8646654
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
[TBL] [Abstract][Full Text] [Related]
8. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
Hu DY; Zhang HP; Sun YH; Jiang LQ;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
11. Prevention of thromboembolic events in atrial fibrillation.
Koefoed BG; Gulløv AL; Petersen P
Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
; Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
N Engl J Med; 1990 Nov; 323(22):1505-11. PubMed ID: 2233931
[TBL] [Abstract][Full Text] [Related]
13. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
14. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
16. Warfarin for atrial fibrillation. The patient's perspective.
Man-Son-Hing M; Laupacis A; O'Connor A; Wells G; Lemelin J; Wood W; Dermer M
Arch Intern Med; 1996 Sep; 156(16):1841-8. PubMed ID: 8790079
[TBL] [Abstract][Full Text] [Related]
17. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
18. Warfarin therapy and systolic hypertension in men with atrial fibrillation.
Krishnan S; Chawla N; Ezekowitz MD; Peixoto AJ
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1592-9. PubMed ID: 16364831
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in atrial fibrillation.
Turpie AG; Connolly SJ
Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Pengo V; Legnani C; Noventa F; Palareti G;
Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]